Latest Articles

Distinguished professors

13 December 2011

Three Maurice Wilkins Centre investigators are amongst the thirteen professors who have been appointed to the rank of Distinguished Professor at The University of Auckland – principal investigators Margaret Brimble and Bill Denny, and associate investigator Ian Reid.

read more

Centre research features in “Ever Wondered”

25 August 2011

TVNZ New Zealand science programme Ever Wondered dedicated an entire episode, which screened for the first time today, to the research of Maurice Wilkins Centre investigators from the Auckland Cancer Society Research Centre (ACSRC)

read more

Second New Zealand anticancer “stealth” drug targeted for clinical development

4 August 2011

A second anticancer “stealth” drug designed by New Zealand scientists has been targeted for clinical development under a collaborative agreement between Proacta Incorporated (San Diego) and Yakult Honsha Co., Ltd. (Tokyo).

read more

Compound designed in New Zealand starves cancer cells of glucose

4 August 2011

Scientists from the Auckland Cancer Society Research Centre (ACSRC) and Maurice Wilkins Centre for Molecular Biodiscovery have designed a new compound that starves certain cancer cells of glucose, depriving them of energy.

read more

Clues on antipsychotic drugs side effects offer hope

5 July 2011

Weight-gain and diabetes-like symptoms are common side effects of antipsychotic medications, and New Zealand research into the chemical changes involved is raising hope that these effects may be better managed or eliminated.

read more

New Zealand cancer drug to commence clinical trials

13 June 2011

A novel cancer drug designed by scientists from The University of Auckland and Maurice Wilkins Centre for Molecular Biodiscovery, and licensed to university spin-out company Pathway Therapeutics, Inc., has received approval from the US Food and Drug Administration to enter c...

read more

New Zealand-designed anti-tumour agent to enter clinical development

7 June 2011

A novel anti-tumour agent, CEN-209, created by New Zealand scientists will enter clinical development under two international agreements announced last week.

read more

Founding Chair named Fellow of The University of Auckland

Founding Chair named Fellow of The University of Auckland

29 April 2011

William Falconer CNZM LL.B. has been named a Fellow of The University of Auckland. The honour, conferred during Autumn Graduation, recognises his outstanding contribution to the University as Founding Chair of the Board of the Maurice Wilkins Centre for Molecular Biodiscover...

read more